The breast cancer 'breakthrough' is a story of overtreatment, not a triumph of testing, says Dr Clare Craig. The truth is, the genetic test failed, but it's being rolled out anyway.
Thousands of women could be left without vital breast cancer and endometriosis medicine when AstraZeneca removes its treatment from the Pharmaceutical Benefits Scheme (PBS) and the private market, experts warn.
Zoladex will no longer be available in Australia from November, as the ABC first reported, but some existing patients will still be able to access it for an additional six months.
Login
